Notas del episodio
Drug development is notoriously time-consuming and expensive, but what if we could simulate clinical trials before they even begin? Orr Inbar, Co-Founder and CEO of QuantHealth, joins me to explore how his team is doing just that. By simulating trials with AI-native models, QuantHealth helps pharmaceutical companies make better decisions about how to design trials and test drugs.
Orr shares how QuantHealth uses real-world patient data and detailed drug biology to build deep-learning models capable of forecasting patient responses to new therapies. He breaks down their biggest challenges…
Web: pixelscientia.com

